Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
May 7th, 2020
8.4K views
We describe an intracisternal injection that employs a needle bent at the tip that can be stabilized to the skull, thus eliminating the risk of damage to the underlying parenchyma. The approach can be used for genetic fate mapping and manipulations of leptomeningeal cells and for tracking cerebrospinal fluid movement.
Overview
This study outlines a novel intracisternal injection technique utilizing a bent needle, aimed at stabilizing the injection site and minimizing damage to underlying tissues. The method enables precise genetic manipulations in leptomeningeal cells and provides insights into cerebrospinal fluid movement dynamics in various physiological and pathological contexts.
Key Study Components
Area of Science
- Neuroscience
- Genetic Engineering
- Surgical Techniques
Background
- Studies on leptomeningeal cells' role in neurodevelopment and pathology are essential for understanding related diseases.
- Traditional methods of injecting substances into the cerebrospinal fluid can risk damage to underlying neural tissue.
- The development of stable delivery techniques can enhance the reliability of genetic studies and tracking mechanisms.
Purpose of Study
- To present a safe method for intracisternal injections using a secured bent needle.
- To facilitate genetic fate mapping and manipulation of leptomeningeal cells.
- To track the movement of cerebrospinal fluid efficiently.
Methods Used
- The study employs a surgical procedure designed for intracisternal delivery of endoxifen using a specially bent needle.
- The key biological model involves transgenic mice expressing CreER under the Cx30 promoter, enabling targeted genetic manipulation.
- Critical steps include precise positioning of the animal and careful management of injection techniques to minimize tissue trauma.
- Injection and monitoring procedures are detailed to ensure successful application and recovery of the animal post-surgery.
Main Results
- The technique allows for specific targeting of leptomeningeal cells without affecting neighboring astrocytes.
- Injections successfully resulted in gene recombination, confirmed by Pdgfr-alpha reactivity, validating the method's efficacy.
- The distribution of the endoxifen solution within the cerebrospinal fluid was optimal, enhancing gene editing precision.
Conclusions
- This study demonstrates a refined technique for intracisternal injections that minimizes risks of neural tissue damage while facilitating genetic studies.
- The results highlight the potential for investigating the roles of leptomeningeal cells in various disease models and physiological processes.
- Implications extend to enhancing techniques in neurobiology and underpinning future research in related fields.
Frequently Asked Questions
What are the advantages of the intracisternal injection method?
The method minimizes the risk of damage to adjacent neural tissue while allowing for precise genetic manipulations in leptomeningeal cells.
How is the bent needle positioned for injection?
The needle is securely positioned against the caudal edge of the skull, which stabilizes it during the injection process.
What biological model is used in this study?
Transgenic mice expressing CreER under the Cx30 promoter serve as the primary biological model for targeted gene editing.
What are the key outcomes measured after the procedure?
Key outcomes include successful gene recombination in leptomeningeal cells and monitoring of cerebrospinal fluid flow dynamics.
Can this method be adapted for other studies?
Yes, the technique can be modified for other genetic studies involving different cell types or substances delivered into the cerebrospinal fluid.
What precautions are necessary during the surgical procedure?
Proper anesthetic administration, careful positioning of the animal, and meticulous handling during the injection process are crucial to avoid complications.
Executive Industry Relevance
This protocol enables precise genetic manipulation of leptomeningeal cells via intracisternal injection, supporting target validation in neurodevelopment and meningitis models. By minimizing tissue damage and ensuring reproducible delivery, it enhances predictive confidence in preclinical studies of CNS disorders. The method facilitates mechanistic de-risking by isolating leptomeningeal cell function from confounding parenchymal effects.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of leptomeningeal cell function in neurodevelopment and bacterial meningitis pathways.
- Operational Value: Provides reproducible genetic fate mapping without labeling adjacent astrocytes.
- Strategic Value: Supports target de-risking by confirming cell-type-specific recombination via Pdgfr-alpha reactivity.
Screening & Assay Development
- Scientific Value: Prepares validated leptomeningeal systems for downstream compound screening in CSF-exposed models.
- Operational Value: Ensures standardized delivery via bent needle stabilization against occipital bone.
- Strategic Value: Enables scalable CSF tracking using fluorescently labeled molecules for assay readiness.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant modeling of leptomeningeal roles in corticogenesis and CSF regulation.
- Operational Value: Allows combination with automated infusion systems for constant substance delivery.
- Strategic Value: Facilitates translational continuity from genetic ablation to functional outcome assessment.
Pipeline & Workflow Integration
The method integrates into discovery workflows by enabling early target hypothesis testing in leptomeningeal systems prior to lead identification.
- Discovery Biology: Supports mechanistic de-risking through cell-specific gene editing in meninges.
- Screening: Delivers quantitative CSF distribution readouts for compound exposure assessment.
- Analytics: Provides Pdgfr-alpha-based recombination metrics to validate target engagement.
- Translational Research: Connects to preclinical validation via tracking of bacterial spread in subarachnoid space.
- Enterprise Reuse: Adaptable across genetic models and substances for platform reuse in CNS target validation.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by isolating leptomeningeal effects from cortical astrocytes.
- Operational Value: Ensures reproducibility through standardized needle positioning and injection technique.
- Strategic Value: Improves go/no-go decisions by validating target specificity in meninges.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on leptomeningeal pathway modulation.
Implementation Considerations
- Requires expertise in microsurgery and CSF anatomy for accurate cisterna magna access.
- Dependent on precision instrumentation including Hamilton syringes and bent needle preparation.
- Necessitates cross-team standardization of animal positioning and injection speed.
- Adaptation considerations include model-specific adjustments for CSF volume and flow dynamics.
- Practical limitations include technical skill dependency and potential variability in needle-bent angle consistency.
Biopharma FAQs
Why does needle stabilization matter for target validation?
Stabilizing the bent needle against the occipital bone prevents deeper tissue penetration after dural puncture, ensuring precise delivery to the subarachnoid space. This minimizes off-target effects and supports reliable leptomeningeal-specific gene editing.
How does endoxifen concentration affect experimental outcomes?
Endoxifen is diluted in 10% DMSO to 1 mg/mL for backfilling the syringe, enabling controlled intracisternal delivery. This concentration supports efficient CreER-mediated recombination in leptomeningeal cells without parenchymal astrocyte labeling.
What quantitative measurements confirm successful gene editing?
Successful recombination is confirmed by Pdgfr-alpha reactivity in leptomeningeal cells, while Gfap expression remains absent in surface and parenchymal astrocytes. This provides a quantitative readout for target-specific editing efficiency.
Why are replication requirements important for CSF flow studies?
Replication ensures consistent distribution of injected compounds throughout the subarachnoid space via natural CSF flow. This supports reliable tracking of cerebrospinal fluid movement and bacterial spreading models.
What statistical analysis is needed before implementing this method?
Pre-implementation requires validation of recombination specificity and CSF distribution consistency across animals. Statistical comparison of Pdgfr-alpha+ cell labeling versus Gfap+ controls ensures method reliability for downstream applications.
